These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6927449)

  • 21. Molecular basis of thalassemia intermedia in Iran.
    Akbari MT; Izadi P; Izadyar M; Kyriacou K; Kleanthous M
    Hemoglobin; 2008; 32(5):462-70. PubMed ID: 18932071
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A rare thalassemia intermedia case caused by co-existence of Hb H disease (--(SEA)/-alpha(4.2)) and beta-thalassemia major (beta (CD17A)>T/beta (IVS2-654C)>T): implications for prenatal diagnosis].
    Li Q; Li LY; Mo QH
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jan; 28(1):16-9. PubMed ID: 18227017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive dysfunction in beta-thalassemia minor.
    Nevruz O; Ulas U; Cetin T; Kutukcu Y; Kurekci A
    Am J Hematol; 2007 Mar; 82(3):203-7. PubMed ID: 17078021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Globin chain synthesis analysis in obligate beta 0-thalassemia heterozygotes with isolated increase of hemoglobin A2 levels.
    Galanello R; Melis MA; Furbetta M; Angius A; Scalas MT; Paglietti E; Cao A
    Nouv Rev Fr Hematol (1978); 1981; 23(4):193-5. PubMed ID: 7312613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thalassemia intermedia: revisited.
    Taher A; Isma'eel H; Cappellini MD
    Blood Cells Mol Dis; 2006; 37(1):12-20. PubMed ID: 16737833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exchange blood transfusions for the treatment of leg ulcerations in thalassemia intermedia.
    Aessopos A; Kati M; Tsironi M; Polonifi E; Farmakis D
    Haematologica; 2006 May; 91(5 Suppl):ECR11. PubMed ID: 16709519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and hematological characteristics of beta-thalassemia trait in Gaziantep urban area, Turkey.
    Gurbak M; Sivasli E; Coskun Y; Bozkurt AI; Ergin A
    Pediatr Hematol Oncol; 2006; 23(5):419-25. PubMed ID: 16728362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydroxyurea in thalassemia intermedia--a promising therapy.
    Dixit A; Chatterjee TC; Mishra P; Choudhry DR; Mahapatra M; Tyagi S; Kabra M; Saxena R; Choudhry VP
    Ann Hematol; 2005 Jul; 84(7):441-6. PubMed ID: 15838670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Thalassemia intermedia caused by interaction of IVS-1 1(G--A) mutation in the beta-globin gene and heterozygotic triplication in the alpha-globin gene].
    Martínez-López J; Galán García P; del Río E; Baiget M; Gilsanz Rodríguez F
    Rev Clin Esp; 1998 Mar; 198(3):153-5. PubMed ID: 9586437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphism analysis in the COLIA1 gene of patients with thalassemia major and intermedia.
    Arisal O; Deviren A; Fenerci EY; Hacihanefioglu S; Ulutin T; Erkmen S; Buyru N
    Haematologia (Budap); 2002; 32(4):475-82. PubMed ID: 12803121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coagulation and splenectomy: an overview.
    Cappellini MD; Grespi E; Cassinerio E; Bignamini D; Fiorelli G
    Ann N Y Acad Sci; 2005; 1054():317-24. PubMed ID: 16339680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Anemia 2,3-DPG and tissue oxygenation in beta-thalassemia heterozygotes].
    Tassiopoulos T; Kaltsoya-Tassiopoulos A; Alchanati N; Rombos J; Pournaras N; Fessas P
    Nouv Rev Fr Hematol (1978); 1982; 24(6):359-62. PubMed ID: 7167385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exercise capacity in patients with beta-thalassaemia intermedia.
    Agostoni P; Cerino M; Palermo P; Magini A; Bianchi M; Bussotti M; Fiorelli G; Cappellini MD
    Br J Haematol; 2005 Oct; 131(2):278-81. PubMed ID: 16197461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypocholesterolemia in adult patients with thalassemia: a link with the severity of genotype in thalassemia intermedia patients.
    Ricchi P; Ammirabile M; Spasiano A; Costantini S; Di Matola T; Cinque P; Pagano L; Prossomariti L
    Eur J Haematol; 2009 Mar; 82(3):219-22. PubMed ID: 19215610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thalassemia intermedia associated with the Hb Constant Spring EE Bart's disease in pregnancy: a molecular and hematological analysis.
    Fucharoen S; Fucharoen G; Sae-ung N; Sanchaisuriya K
    Blood Cells Mol Dis; 2007; 39(2):195-8. PubMed ID: 17587614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Red blood cell vesicles in thalassemia.
    Lamchiagdhase P; Nitipongwanich R; Rattanapong C; Noulsri E; Lerdwana S; Pattanapanyasat K
    J Med Assoc Thai; 2004 Mar; 87(3):233-8. PubMed ID: 15117038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Response to hydroxyurea in beta thalassemia major and intermedia: experience in western India.
    Italia KY; Jijina FJ; Merchant R; Panjwani S; Nadkarni AH; Sawant PM; Nair SB; Ghosh K; Colah RB
    Clin Chim Acta; 2009 Sep; 407(1-2):10-5. PubMed ID: 19545554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of liver iron concentration determined by R2 magnetic resonance imaging with serum ferritin in patients with thalassemia intermedia.
    Taher A; El Rassi F; Isma'eel H; Koussa S; Inati A; Cappellini MD
    Haematologica; 2008 Oct; 93(10):1584-6. PubMed ID: 18728025
    [No Abstract]   [Full Text] [Related]  

  • 39. Two thalassemia intermedia patients with delta beta/beta-thalassemia and a deletional type alpha-thalassemia.
    Li Z; Liu L; Zhao Y; Zhong X; Xu X
    Haematologica; 2001 Jan; 86(1):108. PubMed ID: 11146584
    [No Abstract]   [Full Text] [Related]  

  • 40. Serum transferrin receptor levels in patients with thalassemia intermedia during rHuEPO administration.
    Dore F; Bonfigli S; Gaviano E; Pardini S; Longinotti M
    Haematologica; 1996; 81(1):37-9. PubMed ID: 8900849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.